KPIs & Operating Metrics(New)
Growth Metrics

Colgate Palmolive (CL) Capital Expenditures (2016 - 2026)

Colgate Palmolive has reported Capital Expenditures over the past 18 years, most recently at $138.0 million for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 11.29% year-over-year to $138.0 million; the TTM value through Mar 2026 reached $578.0 million, up 3.4%, while the annual FY2025 figure was $564.0 million, 0.53% up from the prior year.
  • Capital Expenditures for Q1 2026 was $138.0 million at Colgate Palmolive, down from $177.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $221.0 million in Q4 2022 and troughed at $108.0 million in Q2 2025.
  • A 5-year average of $156.7 million and a median of $161.0 million in 2023 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 36.92% in 2022 and later crashed 36.41% in 2024.
  • Year by year, Capital Expenditures stood at $221.0 million in 2022, then fell by 10.86% to $197.0 million in 2023, then dropped by 6.6% to $184.0 million in 2024, then fell by 3.8% to $177.0 million in 2025, then decreased by 22.03% to $138.0 million in 2026.
  • Business Quant data shows Capital Expenditures for CL at $138.0 million in Q1 2026, $177.0 million in Q4 2025, and $155.0 million in Q3 2025.